Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis
- PMID: 8423629
- DOI: 10.1093/jnci/85.3.235
Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis
Abstract
Background: Stable anchorage of circulating cancer cells to the vasculature is a critical step in the formation of hematogenous metastases. Although the basement membrane glycoprotein laminin clearly plays a crucial role in this event, the exact interactive pathways among cancer cells, laminin, and the vessel wall have not been elucidated. In a previous study, we identified synthetic peptide G, which contains the laminin-binding domain of the 67-kd laminin receptor and which inhibits tumor cell adhesion to endothelial cells.
Purpose: To assess the role of the interaction between laminin and the 67-kd laminin receptor in hematogenous metastasis formation, we studied the effect of peptide G on melanoma cell behavior in vivo and in vitro.
Methods: The effect of peptide G and control peptides was studied in vivo on lung retention and colonizing potential of murine (B16BL6) and human (A2058) melanoma cells injected intravenously in C57BL/6 and nude mice, respectively. In addition, their effect on cell adhesion and chemotaxis to laminin and on binding of iodine 125-labeled laminin to cells was studied in vitro.
Results: In vivo, pretreatment of cells with peptide G resulted in a two- to 10-fold significant increase in the number of experimental lung metastases. A significant relative increase in lung retention of peptide G-treated tumor cells was observed 48 hours after injection, although after 4 hours a partial reduction was observed. In vitro, peptide G significantly increased laminin binding and cancer cell adhesion to laminin and subendothelial matrix, whereas chemotaxis to laminin was significantly inhibited.
Conclusions: Peptide G differentially affected the biological response of cancer cells to laminin. In vitro, it increased laminin binding and cell adhesion to laminin and subendothelial matrix, whereas it inhibited cell chemotaxis to laminin. In vivo, the overall effect of peptide G was an augmentation of lung metastasis.
Implications: Our findings suggest that direct adhesion of tumor cells to the subendothelial matrix is a main pathway for hematogenous metastases and that tumor cell-matrix interaction may be more relevant than tumor cell-endothelial cell attachment in this process.
Similar articles
-
Control pathways of the 67 kDa laminin binding protein: surface expression and activity of a new ligand binding domain.Clin Exp Metastasis. 1995 Sep;13(5):357-72. doi: 10.1007/BF00121912. Clin Exp Metastasis. 1995. PMID: 7641420
-
Interactions of a laminin-binding peptide from a 33-kDa protein related to the 67-kDa laminin receptor with laminin and melanoma cells are heparin-dependent.J Biol Chem. 1992 Sep 5;267(25):17743-7. J Biol Chem. 1992. PMID: 1387642
-
Laminin receptor complementary DNA-deduced synthetic peptide inhibits cancer cell attachment to endothelium.Cancer Res. 1991 Oct 15;51(20):5672-8. Cancer Res. 1991. PMID: 1833053
-
Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis.Semin Cancer Biol. 1993 Aug;4(4):259-65. Semin Cancer Biol. 1993. PMID: 8400148 Review.
-
Laminin-111-derived peptides and cancer.Cell Adh Migr. 2013 Jan-Feb;7(1):150-256. doi: 10.4161/cam.22827. Epub 2012 Dec 21. Cell Adh Migr. 2013. PMID: 23263633 Free PMC article. Review.
Cited by
-
On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities.Pharmaceuticals (Basel). 2015 Jul 31;8(3):455-73. doi: 10.3390/ph8030455. Pharmaceuticals (Basel). 2015. PMID: 26263999 Free PMC article. Review.
-
Comprehensive proteomic analysis of nonintegrin laminin receptor interacting proteins.J Proteome Res. 2012 Oct 5;11(10):4863-72. doi: 10.1021/pr300307h. Epub 2012 Aug 29. J Proteome Res. 2012. PMID: 22909348 Free PMC article.
-
Reconsideration of the laminin receptor 67LR in colorectal cancer cells.Biomol Biomed. 2024 Sep 6;24(5):1117-1132. doi: 10.17305/bb.2024.10323. Biomol Biomed. 2024. PMID: 38606907 Free PMC article.
-
67 kDa laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach?Transl Med UniSa. 2016 Nov 1;15:8-14. eCollection 2016 Nov. Transl Med UniSa. 2016. PMID: 27896222 Free PMC article.
-
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion.Oncotarget. 2015 Jul 20;6(20):18116-33. doi: 10.18632/oncotarget.4016. Oncotarget. 2015. PMID: 26062445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical